Table 3.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
|
||||||
HR | p | HR | 95% CI | p | ||
Age | >65 | Reference | 0.0641 | |||
≤65 | 1.539 | |||||
Sex | Male | Reference | 0.4369 | |||
Female | 1.257 | |||||
Pathology | Non-clear | Reference | 0.0035 | Reference | 0.0110 | |
Clear | 0.432 | 0.477 | 0.269–0.844 | |||
KPS | ≥80% | Reference | 0.2527 | |||
<80% | 1.573 | |||||
Anemia | (−) | Reference | 0.0004 | Reference | 0.0658 | |
(+) | 2.201 | 1.557 | 0.971–2.495 | |||
Hypercalcemia | (−) | Reference | <0.0001 | Reference | 0.0005 | |
(+) | 10.315 | 5.233 | 2.074–13.203 | |||
Time from diagnosis to treatment | <1 year | Reference | 0.0002 | Reference | 0.0072 | |
≥1 year | 0.407 | 0.479 | 0.280–0.819 | |||
Liver metastasis | (+) | Reference | 0.2816 | |||
(−) | 0.705 | |||||
Bone metastasis | (+) | Reference | 0.3267 | |||
(−) | 0.793 | |||||
SII | ≤730 | Reference | <0.0001 | Reference | 0.0259 | |
>730 | 2.424 | 1.721 | 1.067–2.774 |
CI: confidence interval; HR: hazard ratio; KPS: Karnofsky Performance Status; SII: systemic immune inflammation index.